Although the AMPK signaling pathway has emerged as a pivotal molecule in recent investigations exploring the association between CS and MASLD, it is noteworthy that CS exerts its influence on liver steatosis through diverse alternative pathways. This evidence concerns the gene PRKAA1 and metabolic dysfunction-associated steatotic liver disease.